
Bostonia is published in print three times a year and updated weekly on the web.
In Klapperich’s lab, students and researchers are developing tests for malaria, chlamydia, gonorrhea, and more. “There are all kinds of applications” for paper-based testing, says Klapperich, here with PhD candidate Justin Rosenbohm (ENG’20). “And it makes the students who come work for me a much broader group of people.” Photo by Jackie Ricciardi
“A private little revolution any woman can easily buy at her drugstore.”
That’s how a 1978 ad described the new-to-market home pregnancy test. Today, that revolution is replayed in millions of American bathrooms every year—so many that it hardly feels revolutionary anymore.
But Catherine Klapperich understands just how powerful it is to have direct access to your medical information. She’s working to make that “little revolution” a lot bigger through simple, portable tests for conditions like HPV, malaria, and chlamydia that patients can use worldwide.
“In a fragmented healthcare system like ours and like many around the world, you have to be your own advocate,” says Klapperich, a College of Engineering professor of biomedical engineering and materials science and engineering, director of the Center for Future Technologies in Cancer Care (CFTCC), and ENG associate dean for research and technology development. “Being the best advocate you can be requires information. Information is power.”
Related Stories
Wearable Windows into Breast Tumors
ENG’s Darren Roblyer is developing technology to help doctors choose best therapies
You’ve Heard of Single-Payer. What about All-Payer Healthcare?
BU’s Austin Frakt talks about a different way to control runaway prices
Chen, Biomedical Engineer, Recognized with Pritzker Award
Biomedical Engineering Society’s premier honor, given for outstanding achievements, leadership
Post Your Comment